These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16877660)

  • 41. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
    Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
    Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population.
    Brar JS; Parepally H; Chalasani L; Gopalani A; Appel N; Chengappa KN
    Ann Clin Psychiatry; 2008; 20(3):139-44. PubMed ID: 18633740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
    Woods SW; Morgenstern H; Saksa JR; Walsh BC; Sullivan MC; Money R; Hawkins KA; Gueorguieva RV; Glazer WM
    J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroleptic discontinuation and tardive dyskinesia risk.
    Sherr JD; Medoff D; Thaker G
    Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483
    [No Abstract]   [Full Text] [Related]  

  • 46. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN; Matroos GE; Hoek HW; Kahn RS
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevalence of extrapyramidal effects by neuroleptics in admitted people with schizophrenia].
    Moreno-Calvete MC
    Enferm Clin; 2013; 23(3):114-7. PubMed ID: 23755945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders.
    Bergman J; Dwolatzky T; Brettholz I; Lerner V
    J Clin Psychiatry; 2005 Jan; 66(1):107-10. PubMed ID: 15669896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accelerometric assessment of tardive dyskinesia.
    Tryon WW; Pologe B
    Am J Psychiatry; 1987 Dec; 144(12):1584-7. PubMed ID: 2891307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New-onset tardive dyskinesia in patients with first-episode psychosis receiving risperidone or haloperidol.
    Gharabawi GM; Bossie CA; Zhu Y
    Am J Psychiatry; 2006 May; 163(5):938-9. PubMed ID: 16648343
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial.
    Emsley R; Niehaus DJ; Koen L; Oosthuizen PP; Turner HJ; Carey P; van Rensburg SJ; Maritz JS; Murck H
    Schizophr Res; 2006 May; 84(1):112-20. PubMed ID: 16632329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes and development of tardive dyskinesia.
    Woerner MG; Saltz BL; Kane JM; Lieberman JA; Alvir JM
    Am J Psychiatry; 1993 Jun; 150(6):966-8. PubMed ID: 8098587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 60. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.